Journal Watch - Icodextrin

« Back to Most Recent

  1. Biocompatible PD Solutions Maintain Membranes Longer

    Independently of inflammation, biocompatible PD solutions helped 71 patients keep a steady level of solute transport over 7.5 years, compared to 295 patients who used standard solutions. Read the abstract.

    Read the abstract » | (added 09/10/2018)

    Tags: Dialysis Solutions, Glucans, Glucose, Il6 Protein, Human, Inflammation, Interleukin 6, Peritoneal Fibrosis, Peritoneum, Peritonitis, Creatinine, Hospitalization, Icodextrin, Peritoneal Dialysis, Peritoneal Membrane

  2. Starting PD with One Daily Exchange of Icodextrin

    Incremental PD can be less restrictive for patients initiating therapy. Is one daily exchange with icodextrin enough? A physiological study used a 3-pore kinetic model to assess fluid and solute removal among patients with residual function that ranged from 0 to 15 mL/min/1.73m2. All but very large patients (total body water >60L) were predicted to achieve adequate dialysis with this approach.

    Read the abstract » | (added 02/15/2018)

    Tags: Incremental Pd, Icodextrin, Fluid And Solute Removal